- Home
- ALVR vs RPID Comparison
ALVR vs RPID Comparison
Compare ALVR & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- RPID
- Stock Information
- Founded
- ALVR 2013
- RPID 2006
- Country
- ALVR United States
- RPID United States
- Employees
- ALVR N/A
- RPID N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- RPID Medical Specialities
- Sector
- ALVR Health Care
- RPID Health Care
- Exchange
- ALVR Nasdaq
- RPID Nasdaq
- Market Cap
- ALVR 48.8M
- RPID 43.5M
- IPO Year
- ALVR 2020
- RPID 2021
- Fundamental
- Price
- ALVR $9.63
- RPID $3.21
- Analyst Decision
- ALVR
- RPID Buy
- Analyst Count
- ALVR 0
- RPID 1
- Target Price
- ALVR N/A
- RPID $8.00
- AVG Volume (30 Days)
- ALVR 22.4K
- RPID 583.3K
- Earning Date
- ALVR 03-14-2025
- RPID 02-28-2025
- Dividend Yield
- ALVR N/A
- RPID N/A
- EPS Growth
- ALVR N/A
- RPID N/A
- EPS
- ALVR N/A
- RPID N/A
- Revenue
- ALVR N/A
- RPID $26,170,000.00
- Revenue This Year
- ALVR N/A
- RPID $25.32
- Revenue Next Year
- ALVR N/A
- RPID $18.92
- P/E Ratio
- ALVR N/A
- RPID N/A
- Revenue Growth
- ALVR N/A
- RPID 27.31
- 52 Week Low
- ALVR $7.96
- RPID $0.58
- 52 Week High
- ALVR $24.15
- RPID $4.04
- Technical
- Relative Strength Index (RSI)
- ALVR 45.63
- RPID 62.15
- Support Level
- ALVR $9.55
- RPID $3.38
- Resistance Level
- ALVR $10.41
- RPID $4.04
- Average True Range (ATR)
- ALVR 0.44
- RPID 0.51
- MACD
- ALVR 0.05
- RPID 0.04
- Stochastic Oscillator
- ALVR 22.77
- RPID 64.11
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.